/PRNewswire/ Peter Rinaldi, DMD, AAACD, is being recognized by Continental Who s Who as a Trusted Dentist for his exemplary contributions in the dental.
/PRNewswire/ GH Research PLC, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders,.
Numinus Announces Grant of Stock Options
News provided by
Share this article
VANCOUVER, BC, June 24, 2021 /PRNewswire/ -
Numinus Wellness Inc. ( Numinus or the Company ) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, announces that it has granted 1,825,000 incentive stock options (the
Options ) to directors, officers and employees of the Company, which are subject to regulatory approval.
Of the 1,825,000 Options granted during the month of May, 810,000 were issued to directors and an officer of Numinus, which have an exercise price of $0.90 per common share and are exercisable until May 19, 2023. The 1,015,000 Options issued to employees have exercise prices ranging between $0.87 and $1.00 with expiry dates ranging from May 1, 2023 to May 17, 2023.
/PRNewswire/ The Washington Health Alliance (Alliance) recently completed a purchaser-led project with the central aim of using data and collective action.
/PRNewswire/ CYFIRMA, a threat discovery and cyber-intelligence platform company, funded by Goldman Sachs, Zodius Capital and Z3Partners, today announced.